THE HEALTH | SEPTEMBER , 2023

The pharmaceutical company is creating a thorough regularisation plan as part of its financial turnaround strategy to list on Bursa Malaysia ’ s main market .

The plan highlights the Group ’ s efforts to re-establish financial stability and raise shareholder value , which is anticipated to be submitted by the third quarter of this year . By the first quarter of 2024 , this initiative is expected to be completed .

Compared to a negative net operating cash flow of RM135.78 million during the same period last year , the pharmaceutical Group reported a positive net operating cash

MANULIFE INSURANCE Berhad ’ s ( Manulife Malaysia ) flagship medical plan – Manulife Health Saver Benefit ( MHSB ) was honoured as the Best Medical Plan for Families at Parenthood ’ s sixth annual Parents ’ Choice Awards .

This achievement marks the second consecutive year in which Manulife Malaysia products have been recognised for their excellence , with the Manulife Precious Gift product flow of RM43.13 million during its most recent six-month period that ended on June 30 , 2023 .

At the end of June , it had RM1.135 billion in borrowings versus RM27.77 million in deposits , cash , and bank balances .

The second placement is anticipated to raise approximately RM50 million in gross proceeds based on the indicative issue price of 35.6 sen and the assumption that 140.45 million shares are issued .

The proceeds from the private placement will be used as a temporary solution to cover the Group ’ s need for working capital . At the same time , it develops a strategy to normalise its financial situation to address its PN17 status .

Pharmaniaga previously raised RM45.86 million through a private placement of 131.02 million new shares , or 10 per cent of its existing share base , on July 24 . The money raised was used as working capital .

IHH Healthcare ( IHH ), a global leader in integrated healthcare services , won the Healthcare Asia Medtech Awards ’ Health App of the Year - Singapore for effectively using its MyHealth360 mobile app .

MyHealth360 is a patient-focused , all-in-one mobile platform that seamlessly connects users to IHH ’ s suite of services , enabling them to keep track of their health whenever and wherever they are .

With the introduction of MyHealth360 , IHH can now provide an excellent user experience . The new applications , which each have multiple features and cater to the needs of both user types by considering user feedback , operational pain points , and user research , attracted over 140,000 patients and 1,600 doctors to register to use them .

Customers of MyHealth360 can choose from various features , such as scheduling appointments , on-demand teleconsultations , purchasing healthcare service bundles , and tracking their health status .

Doctors can easily track and access their patients ’ radiology and lab test results with MyHealth360 and their diagnoses . Doctors can work with other carers and keep up with administrative and hospital policies thanks to this seamless integration .

IHH Healthcare Group Chief Operating Officer Joe Sim said : “ The launch of MyHealth360 is fully aligned to IHH ’ s aspiration to ‘ Care . For Good .’ by making healthcare better , faster , and easier for our patients .

“ It is also a key milestone in our innovation and digital transformation journey , as we seek to empower our users to take control of their health through seamless digital experiences and conveniences across their healthcare journey .”

The Healthcare Asia Medtech

winning the “ Best Child Coverage Plan ” at the Motherhood Choice Awards in 2022 .

MHSB ’ s innovative feature provides 30 per cent Upfront Discount ( UD ) and up to 40 per cent No Claim Discount ( NCD ) on the cost of insurance , allowing customers to benefit in the long run when no claims are made . With the option to add the MHSB Booster , customers will get to ensure their NCD will remain intact

On July 27 , Pharmaniaga was notified by Bursa Malaysia that it was “ unable to consider ” the Company ’ s proposed second private placement of new shares to the Armed Forces Fund Board ( LTAT ). Instead , the stock exchange suggested that the private placement be included in the Company ’ s proposed regularisation plan .

Due to provisions of RM552.3 million for unsold Covid-19 vaccines , Pharmaniaga entered PN17 status in February , resulting in a negative equity position on its balance sheet .

Awards recognise businesses that have overcome the challenges posed by the global financial crisis by creating innovative goods , services , and programmes .

even after reaching age 60 , providing peace of mind during their golden years .

MHSB offers extensive medical coverage for Covid-19 treatment and future pandemics . A notable highlight of the plan is its comprehensive coverage for up to five children under one plan that optimises the cost of insurance while ensuring the entire family receives top-quality medical coverage .

KPJ HEALTHCARE Berhad is optimistic of maintaining its momentum for the upcoming quarters .

According to the Company , the Group ’ s encouraging results should be maintained , and its performance should improve due to its ongoing efforts to increase the number of hospital beds , hire more consultants , and broaden its scope of services , it told Bursa Malaysia .

KPJ ’ s net profit for the second quarter ended June 30 , 2023 , increased to RM46.95 million from RM27.08 million in the prior corresponding period , while revenue rose to RM799.51 million from RM699.34 million . Basic earnings per share increased from 0.62 to 1.08 sen .

KPJ ’ s net profit for the first half of 2023 increased to RM98.84 million from RM49.22 million in the prior corresponding period , while revenue rose to RM1.63 billion from RM1.34 billion the previous year .

KPJ Healthcare announced an interim dividend of 0.8 sen per share , totalling RM34.9 million , to be paid to shareholders on Oct 3 .

KPJ Healthcare Officer in Charge Norhaizam Mohammad said : “ The strategies implemented at the Group and our network of hospitals since the beginning of 2023 have continued to yield favourable outcomes as we capitalised on the resurgence in the healthcare sector .

“ Our focus to be the preferred healthcare provider through measures such as investing in technologies to produce best clinical outcomes for our patients has led to an increased number of surgeries at our hospitals , contributing to improved earnings ”. “ Deliveries were also one of the services that positively contributed to our business during the period under review . With the recent launch of our Women and Children Centre at KPJ Damansara Specialist , we believe it will further strengthen our leading position in providing state-of-the-art and comprehensive care to women and children .”